Johnson & Johnson’s HIV vaccine fails first efficacy trial
An HIV vaccine using the same basic technology as Johnson & Johnson’s Covid shot failed…
Category: HIV/AIDS
Virtual event: The next battles in the war against HIV
Despite many strides in treatment and prevention, the HIV epidemic continues and disproportionately impacts women…
Opinion: 40 years of AIDS should have taught us epidemiologic humility
Forty years later, I can still recall my visceral reaction to reading an article in…
Opinion: A vaccine for my shame
The Covid-19 crisis has revealed all manner of injustices, from hazardous work to overcrowded nursing…
STAT+: Pharmalittle: Merck says early data shows pill is effective against Covid-19; WHO’s COVAX program ships first doses
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: New Mexico attorney general accuses Gilead of blocking competition to its HIV medicines
The New Mexico attorney general has filed a lawsuit against Gilead Sciences (GILD) and two…
FDA approves first monthly injectable medicine to treat HIV infection
In a move that could transform HIV treatment, the Food and Drug Administration has approved…
STAT+: Pharmalittle: Pfizer Covid-19 vaccine shows 95% effectiveness; FDA vows to disclose scientific data for EUAs
Hello, everyone, and welcome to the middle of the week. Congratulations on making it this…
AIDS report: Kids are lagging and Covid-19 is harming care
New numbers on the global AIDS epidemic show some big successes, such as fewer deaths…
STAT Plus: Pharmalittle: Covid-19 trials are marked by disorganization; FDA approves a new type of HIV treatment
Good morning, everyone, and welcome to another working week. We hope the weekend respite, which…
Experimental HIV drug seems effective at a twice-a-year dose, study finds
An experimental new HIV treatment could, with just one dose, reduce the amount of virus…
‘Flying blind’: Doctors race to understand what Covid-19 means for people with HIV
Larry Pike has already survived one pandemic. The 76-year-old Seattle retiree has been living with…
STAT Plus: Pharmalittle: Stressed Americans cause a shortage of an antidepressant; Dems attack GOP candidates over malaria drug
Rise and shine, another busy day is on the way. And it feels particularly busy….
STAT Plus: Pharmalittle: U.K. will get first access to an AstraZeneca Covid-19 vaccine; VA will continue using old malaria drug
Good morning, everyone, and welcome to another working week. We hope the weekend interlude was…
The porn industry tests and traces. Could it offer a model for reopening amid Covid-19?
LOS ANGELES — As states and employers furiously develop plans to safely reopen workplaces in…
STAT Plus: Gilead sues U.S., claiming it ‘secretly’ obtained patents on HIV research that led to Truvada
Gilead Sciences (GILD) has accused the U.S. government of breaching several contracts and “secretly” obtaining…
STAT Plus: AbbVie waives all worldwide restrictions on making generic copies of its Kaletra HIV pill
In an unexpected development, AbbVie (ABBV) is waiving restrictions on licenses held by a nonprofit…
STAT Plus: A recently approved Gilead HIV prevention pill is not cost-effective and should be cut in half, study says
The price of a Gilead Sciences (GILD) pill approved in the U.S. last fall to…
Opinion: Will the newest pill for HIV prevention fuel progress — or profits?
Four decades after the HIV epidemic began, there’s finally hope it might end. Indeed, “Getting…
STAT Plus: Gilead loses another challenge to a pair of U.S. patents for an HIV prevention pill
For the second time this month, Gilead Sciences (GILD) has lost a bid to invalidate…
.jpg)
Opinion: For African women at risk of HIV, a woke world is still sound asleep
The arrival in 2012 of a daily pill to prevent HIV infection was widely hailed…
STAT Plus: Gilead loses its challenge to a pair of U.S. patents over an HIV prevention pill
In a setback to Gilead Sciences (GILD), a federal panel rejected its bid to invalidate…
What will 2020 bring for medicine and science? We asked 16 leaders for predictions
Last year, when we asked science and health care soothsayers to peak ahead to 2019,…
STAT Plus: U.S. Patent Office removes lawyer from high-profile case involving a Gilead HIV medicine
The U.S. Patent and Trademark Office has removed a senior legal adviser from a high-profile…
Trump administration will provide HIV prevention drug for free to uninsured in new program
The Trump administration on Tuesday detailed how it will roll out the delivery of donated…
For babies born with HIV, start treatment right away, study says
WASHINGTON — When babies are born with HIV, starting treatment within hours to days is…